Literature DB >> 26905910

Clinical Manifestations of Isolated Elevated Homocysteine-Induced Peripheral Neuropathy in Adults.

Varun Shandal1, Jin Jun Luo.   

Abstract

OBJECTIVE: To characterize the clinical features of isolated elevated plasma homocysteine (eHcy)-induced peripheral neuropathy (IHIN) in adults.
METHODS: Charts of subjects with the diagnosis of IHIN who visited neuromuscular clinic from January 01, 2012 to September 30, 2014 were reviewed. Subjects with identifiable etiologies for neuropathy, such as B12/folate deficiency; metabolic, toxic, endocrinologic, infectious/inflammatory renal or liver diseases; or traumatic nerve injury, were excluded. Their clinical presentations were recorded and analyzed.
RESULTS: Thirty subjects (age: 63.2 ± 14.8 years, 13 males) were included. They all had an isolated increased homocysteine level (15.4 ± 5.3 μmol/L) but normal levels of B12, folate, and methylmalonic acid. Of 30, 14 (46.7%) had numb feet, 11 (36.7%) had numb hands, 7 (23.3%) had pain in lower extremities, and 10 (33.3%) had tingling in feet. Distal sensory deficits were present in 18/30 (60%) patients. Distal limb weakness was seen in 4 and decreased tendon reflexes in 12 patients.
CONCLUSIONS: Sensory deficits are predominant components of IHIN. Characterizing clinical features of IHIN would help better understand eHcy-related neuropathy and improve its management.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26905910     DOI: 10.1097/CND.0000000000000108

Source DB:  PubMed          Journal:  J Clin Neuromuscul Dis        ISSN: 1522-0443


  4 in total

1.  The Prognostic Value of Homocysteine in Acute Ischemic Stroke Patients: A Systematic Review and Meta-Analysis.

Authors:  Shengming Huang; Jirui Cai; Yuejun Tian
Journal:  Front Syst Neurosci       Date:  2021-02-12

2.  Peripheral Nervous System Involvement in Late-Onset Cobalamin C Disease?

Authors:  Xujun Chu; Lingchao Meng; Wei Zhang; Jinjun Luo; Zhaoxia Wang; Yun Yuan
Journal:  Front Neurol       Date:  2020-11-26       Impact factor: 4.003

3.  Tolcapone improves outcomes in patients with Parkinson disease treated by levodopa/carbidopa intestinal gel: A pilot study.

Authors:  Peter Valkovič; Michal Minár; Peter Matejička; Karin Gmitterová; Veronika Boleková; Zuzana Košutzká
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

4.  Clinical feature and sural biopsy study in nitrous oxide-induced peripheral neuropathy.

Authors:  Qian Wang; Xiaohui Duan; Mingrui Dong; Shaojie Sun; Pan Zhang; Fang Liu; Li Wang; Renbin Wang
Journal:  PLoS One       Date:  2022-09-16       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.